Follow-up care for Astrocytoma refers to the after-treatment protocols conducted by the healthcare team to look after any recurrence, manage the side effects, and monitor the children’s overall health. Both medical and physical examinations are included in the follow-up care of children suffering from Astrocytoma. Watching the recurrence of Astrocytoma are seen in test reports of follow-up care. Many factors influence a child’s specific follow-up care plan for Astrocytoma, including the tumor’s grade and location, the child’s age, and the type of treatment. The doctor will propose checks and testing to check for late effects based on the sort of Astrocytoma treatment the child underwent, involving surgery, chemotherapy and radiation therapy. The physical and psychological impacts of pediatric cancer survivors have been investigated by the Children’s Oncology Group (COG). Managing the side effects while receiving treatment is regarded as children’s critical follow-up care approach. Cancer rehabilitation in follow-up care of Astrocytoma involves physical therapy, career counselling, pain management, nutritional planning, and emotional counselling. Personalizing the follow-up care plan is essential for children having Astrocytoma conducted by the medical care team.
Follow-up Care for Astrocytoma
When a child is diagnosed with Astrocytoma, treatment does not terminate when the active treatment is completed. Your child’s health care team will continue to evaluate their overall health, check for recurrence of the tumor, and manage any adverse effects. It is referred to as follow-up care of Astrocytoma. All children treated for a tumor, including Astrocytoma, should get lifelong care.
Regular physical examinations, medical testing, or both may be part of your child’s follow-up care for Astrocytoma. Doctors will monitor your child’s progress over the coming months and years.
Physical therapy, family or individual counselling, nutritional planning, and educational aid may be advised as part of cancer rehabilitation. The purpose of rehabilitation is to assist survivors and their families in regaining control of many aspects of their lives while remaining as self-sufficient and productive as possible.
Many factors influence a child’s specific follow-up care plan for Astrocytoma, including the tumor’s grade and location, the child’s age, and the type of treatment 1.
Keeping an eye out for a recurrence
Checking for a recurrence, which suggests the tumor has returned, is one purpose of follow-up care for Astrocytoma. Because small pockets of tumor cells may go undetected in the body, a tumor can return. These cells may grow in quantity over time until they appear on test results or create signs or symptoms.
A doctor familiar with your child’s medical history can provide specific information regarding the risk of recurrence during follow-up care of Astrocytoma. The doctor will inquire about your child’s health in detail. Some children may undergo blood or imaging tests as routine follow-up care for Astrocytoma. However, testing recommendations are based on several factors, including the kind, stage, and grade of the tumor at the time of diagnosis and the type of treatment used.
You or a family member may experience stress due to the expectation of a follow-up test of Astrocytoma or the waiting for test results. It is referred to as “scan-xiety.”
Managing Astrocytoma’s long-term and late side effects
Side effects can sometimes last longer than the active therapy period. Long-term side effects are what they’re called. Furthermore, other adverse effects known as late effects may appear months or even years later. Late effects might manifest themselves in practically any part of the body. Physical issues such as heart and lung problems and second malignancies, which are a new sort of tumor that develops in someone who has previously had a tumor, are among them. They also include emotional issues like worry and depression, memory, thinking, concentration, and learning difficulties.
The doctor will propose checks and testing to check for late effects based on the sort of Astrocytoma treatment your child underwent 2.
- Surgery: The dangers and potential adverse effects vary greatly based on the tumor’s location and characteristics.
- Chemotherapy: The medications and doses used determine the hazards and likelihood of secondary malignancies.
- Radiation therapy is a type of treatment that involves the use of Radiation to the head and spine and can cause cognitive and endocrine (hormonal) effects over time. The severity of these adverse effects is determined by the dose and your child’s age.
Your child’s quality of life and any developmental or emotional difficulties are addressed in follow-up Astrocytoma treatment. The physical and psychological impacts of paediatric cancer survivors have been investigated by the Children’s Oncology Group (COG).
Keeping track of a child’s personal health information
You should keep a personal record of your child’s medical information organized and accessible. The doctor will assist you in putting this together. As a result, when your child reaches maturity, they will have a written record of the diagnosis, treatments, and the doctor’s recommendations for follow-up care.
Some children remain under the supervision of their oncologist, while others return to their family doctor or another health care provider. The type, stage, and grade of the tumor, side effects, health insurance rules, and your family’s personal preferences play a role in this decision. Discuss your child’s ongoing medical care and any concerns you have about their future health with the health care staff.
If your child’s follow-up care will be led by a doctor who was not directly involved in their astrocytoma treatment, share the treatment summary and survivorship care plan papers with them and any future health care, professionals. The health care experts who will look after your child for the rest of their lives will need to know specifics about the therapy they received.
- 1.Mucha-Małecka A, Gliński B, Hetnał M, et al. Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors. Rep Pract Oncol Radiother. 2012;17(3):141-145. doi:10.1016/j.rpor.2012.01.007
- 2.Sarica F, Cekinmez M, Tufan K, et al. Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma. Asian J Neurosurg. 2012;7(4):181-190. doi:10.4103/1793-5482.106650